Sana Biotechnology's total assets for Q2 2025 were $361.64M, a decrease of -18.82% from the previous quarter. SANA total liabilities were $239.09M for the fiscal quarter, a 1.14% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.